The association of caffeine and nandrolone decanoate modulates aversive memory and nociception in rats.

Anabolic androgenic steroids Animal model Aversive memory Behavior Caffeine Nandrolone decanoate Nociception Sex differences

Journal

Brain research
ISSN: 1872-6240
Titre abrégé: Brain Res
Pays: Netherlands
ID NLM: 0045503

Informations de publication

Date de publication:
12 Apr 2024
Historique:
received: 29 01 2024
revised: 10 04 2024
accepted: 11 04 2024
medline: 15 4 2024
pubmed: 15 4 2024
entrez: 14 4 2024
Statut: aheadofprint

Résumé

Caffeine and anabolic-androgenic steroids (AAS) are commonly used to improve muscle mass and athletic performance. Nandrolone Decanoate (ND) is one of the most abused AAS worldwide, leading to behavioral changes in both humans and rodents. Caffeine, the most widely consumed psychostimulant globally, is present in various thermogenic and gym supplements. Low and moderate doses of caffeine antagonize adenosine receptors and have been linked to improved memory and pain relief. We have previously demonstrated that consuming caffeine prevents the risk-taking behavior triggered by nandrolone. In this study, we aimed to investigate the long-term effects of ND and caffeine, either alone or in combination, on passive avoidance memory and nociception. We used the step-down and hot-plate tasks in male and female Lister Hooded rats. Our results confirmed the antinociceptive effect of caffeine and indicated that chronic administration of the ND-caffeine association promotes the evocation of aversive memory in female rats.

Identifiants

pubmed: 38615923
pii: S0006-8993(24)00191-4
doi: 10.1016/j.brainres.2024.148937
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148937

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Daniel Bussinger de Souza Penna (D)

Institute of Biomedical Sciences, Program of Biomedical Sciences: Physiology and Pharmacology, Federal Fluminense University, Niteroi, Brazil; Institute of Biology, Program of Neurosciences, Federal Fluminense University, Niteroi, Brazil.

Samara Gumiéro Costa (S)

Institute of Biomedical Sciences, Program of Biomedical Sciences: Physiology and Pharmacology, Federal Fluminense University, Niteroi, Brazil.

Alexandre Dos Santos-Rodrigues (A)

Institute of Biology, Program of Neurosciences, Federal Fluminense University, Niteroi, Brazil.

Pablo Pandolfo (P)

Institute of Biomedical Sciences, Program of Biomedical Sciences: Physiology and Pharmacology, Federal Fluminense University, Niteroi, Brazil; Institute of Biology, Program of Neurosciences, Federal Fluminense University, Niteroi, Brazil. Electronic address: pablopandolfo@gmail.com.

Classifications MeSH